全球医药行业竞争力分析：欧洲视角（ 共七章，101页）

是 否 +2 论坛币

k人 参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群

赵安豆老师微信：zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

立即领取

感谢您参与论坛问题回答

经管之家送您两个论坛币！

+2 论坛币

GLOBAL COMPETITIVENESS IN PHARMACEUTICALS： A EUROPEAN PERSPECTIVE

Report Prepared for the Directorate General Enterprise of the European Commission

目录

I. INTRODUCTION............................................................................................... 2
II. STRUCTURAL INDICATORS IN THE EU, USA, AND JAPAN.................. 11
III. THE EUROPEAN AND US MULTINATIONALS: COMPARATIVE
PERFORMANCE ...................................................................................................... 25
IV. R&D AND INNOVATION AS SOURCES OF COMPETITIVE
ADVANTAGES.......................................................................................................... 36
IV.1 THE DIVISION OF INNOVATIVE LABOUR IN PHARMACEUTICALS....................... 36
IV.2 THE US AS AN INCREASINGLY PREFERRED LOCATION FOR INVENTION?............ 39
IV.3 COLLABORATION IN RESEARCH, MARKETS FOR TECHNOLOGY, AND
IMPLICATIONS FOR COMPETITIVENESS..................................................................... 43
IV.4 DRUG RESEARCH TOOLS: ANOTHER LARGELY US PHENOMENON?.................. 53
V. THE ROLE OF COMPETITION.................................................................... 57
VI. INSTITUTIONAL DETERMINANTS OF INDUSTRIAL
COMPETITIVENESS ............................................................................................... 66
VI.1 EDUCATION AND RESEARCH IN BIOMEDICAL INNOVATION SYSTEMS............... 67
VI.2 FINANCIAL MARKETS, CORPORATE GOVERNANCE, AND LABOUR
MARKETS FOR SKILLED RESEARCHERS AND MANAGERS. ........................................ 73
VI.3 PROTECTION OF INTELLECTUAL PROPERTY RIGHTS ......................................... 76
VI.4 DEGREES AND FORMS OF COMPETITION ON THE FINAL MARKET...................... 78
VII. CONCLUSIONS ........................................................................................... 82
VII.1. SUMMARY OF THE MAIN RESULTS AND ISSUES ............................................... 82
VII.2 GLOBAL COMPETITIVENESS IN PHARMACEUTICALS. AN INTERPRETATIVE
FRAMEWORK........................................................................................................... 86

扫码加我 拉你入群

请注明：姓名-公司-职位

以便审核进群资格，未注明则拒绝

分享0 收藏2 回帖

关键词：行业竞争力 医药行业 行业竞争 竞争力 Determinants 竞争力 全球 视角 欧洲 医药行业

dingdingding

加点人气.........

谢谢 顶起来

中文的就好了，英文的看不懂

太贵，还是太贵了。